NEAM
PJP icon

New England Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

New England Asset Management’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,000
Closed -$188K – 157
2017
Q2 		$188K Hold
3,000
– – 0.01% 113
2017
Q1 		$176K Hold
3,000
– – ﹤0.01% 139
2016
Q4 		$168K Buy
+3,000
New +$173K ﹤0.01% 147

Other funds holding PJP

TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

New England Asset Management's PJP Position: Q3 2017 in Review

New England Asset Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2017, closing a stake of 3,000 shares — an estimated $188K sold.

New England Asset Management first reported a position in PJP in Q4 2016 and held it in 3 quarters. The position peaked at $188K in Q2 2017. 90 funds tracked by Wall St. Rank hold PJP as of Q3 2017.

  • New England Asset Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
  • New England Asset Management sold 3,000 Invesco Pharmaceuticals ETF shares in Q3 2017, an estimated $188K.
  • New England Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 3 quarters.
  • New England Asset Management's Invesco Pharmaceuticals ETF position peaked at $188K in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2017.

Based on New England Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.